We are currently reviewing cases involving the prescription drug Xarelto which is manufactured by Janssen Pharmaceutical and co-marketed by Bayer Healthcare. It is alleged these companies failed to warn patients and physicians of the increased risks of irreversible and fatal internal bleeding when using Xarelto. Usage of Xarelto In 2011, Johnson and Johnson introduced Xarelto…
We have begun reviewing claims involving Lipitor which is a member of the drug class known as statins. It is prescribed to reduce cholesterol. Parke-Davis Pharmaceutical Research, a division of Warner-Lambert Company, obtained approval from the Food and Drug Administration (FDA) to market Lipitor on December 17, 1996. Warner-Lambert entered into a co-marketing agreement with…
